The latest edition of the Model List of Essential Medicines (EML), published on July 26, 2023, now includes acamprosate and naltrexone for treating alcohol use disorders in adults. Alcohol use disorders affect nearly 300 million people worldwide, contributing to 3 million deaths annually. This marks the first time any medications for alcohol use disorders have been included, reflecting the recognition of their public health importance and treatment effectiveness.
August 8, 2023